Twist Bioscience Corporation (TWST)

USD 39.82

(2.5%)

Total Liabilities Summary of Twist Bioscience Corporation

  • Twist Bioscience Corporation's latest annual total liabilities in 2023 was 152.97 Million USD , down -11.06% from previous year.
  • Twist Bioscience Corporation's latest quarterly total liabilities in 2024 Q3 was 146.97 Million USD , up 2.99% from previous quarter.
  • Twist Bioscience Corporation reported annual total liabilities of 171.99 Million USD in 2022, up 41.82% from previous year.
  • Twist Bioscience Corporation reported annual total liabilities of 121.27 Million USD in 2021, up 93.67% from previous year.
  • Twist Bioscience Corporation reported quarterly total liabilities of 142.71 Million USD for 2024 Q2, down -0.04% from previous quarter.
  • Twist Bioscience Corporation reported quarterly total liabilities of 142.77 Million USD for 2024 Q1, down -6.67% from previous quarter.

Annual Total Liabilities Chart of Twist Bioscience Corporation (2023 - 2016)

Historical Annual Total Liabilities of Twist Bioscience Corporation (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 152.97 Million USD -11.06%
2022 171.99 Million USD 41.82%
2021 121.27 Million USD 93.67%
2020 62.62 Million USD 79.37%
2019 34.91 Million USD -88.99%
2018 317.21 Million USD 44.84%
2017 219.01 Million USD 43.08%
2016 153.07 Million USD 0.0%

Peer Total Liabilities Comparison of Twist Bioscience Corporation

Name Total Liabilities Total Liabilities Difference
Aspira Women's Health Inc. 8.62 Million USD -1673.166%
bioAffinity Technologies, Inc. 3.36 Million USD -4444.192%
Intelligent Bio Solutions Inc. 5.59 Million USD -2633.738%
Standard BioTools Inc. 159.86 Million USD 4.312%
Inotiv, Inc. 588.04 Million USD 73.986%
Prenetics Global Limited 44.01 Million USD -247.557%
Neuronetics, Inc. 81.64 Million USD -87.37%
Star Equity Holdings, Inc. 21.67 Million USD -605.749%
Castle Biosciences, Inc. 86.54 Million USD -76.759%
Psychemedics Corporation 6.59 Million USD -2218.445%
RadNet, Inc. 2.07 Billion USD 92.622%
Exact Sciences Corporation 3.32 Billion USD 95.401%
IDEXX Laboratories, Inc. 1.77 Billion USD 91.384%
iSpecimen Inc. 6.07 Million USD -2416.773%
OpGen, Inc. 13.44 Million USD -1037.85%
Exagen Inc. 34.25 Million USD -346.631%
Bionano Genomics, Inc. 118.24 Million USD -29.366%
CareDx, Inc 223.28 Million USD 31.491%
Check-Cap Ltd. 1.33 Million USD -11401.579%
Guardant Health, Inc. 1.62 Billion USD 90.602%
Biodesix, Inc. 94.51 Million USD -61.847%
BioNexus Gene Lab Corp. 1.74 Million USD -8681.641%
Precipio, Inc. 3.67 Million USD -4065.877%
Natera, Inc. 691.79 Million USD 77.888%
Fulgent Genetics, Inc. 139.82 Million USD -9.403%
Sera Prognostics, Inc. 25.28 Million USD -505.035%
23andMe Holding Co. 206.64 Million USD 25.975%
OPKO Health, Inc. 622.47 Million USD 75.426%
Personalis, Inc. 95.65 Million USD -59.914%
Aclaris Therapeutics, Inc. 40.22 Million USD -280.279%
Applied DNA Sciences, Inc. 8.77 Million USD -1642.432%
T2 Biosystems, Inc. 62.83 Million USD -143.456%
Neogen Corporation 1.44 Billion USD 89.377%
Myriad Genetics, Inc. 312.9 Million USD 51.112%
ICON Public Limited Company 7.74 Billion USD 98.026%
NeoGenomics, Inc. 739.69 Million USD 79.32%
Star Equity Holdings, Inc. 21.67 Million USD -605.749%
MDxHealth SA 121.92 Million USD -25.464%
Prenetics Global Limited 44.01 Million USD -247.557%
Illumina, Inc. 4.36 Billion USD 96.496%
DarioHealth Corp. 38.24 Million USD -299.976%
ENDRA Life Sciences Inc. 1.09 Million USD -13867.952%
Medpace Holdings, Inc. 1.09 Billion USD 86.067%
Mainz Biomed B.V. 12.15 Million USD -1158.006%
Trinity Biotech plc 83.38 Million USD -83.454%
Sotera Health Company 2.68 Billion USD 94.306%
bioAffinity Technologies, Inc. 3.36 Million USD -4444.192%